Hogue Vein Institute realizes there are multiple FDA-cleared technologies and modalities available to physician vein specialists when treating symptomatic varicose veins and superficial venous disease. Payable benefits and allowable amounts by Medicare and private insurers vary drastically for these available treatments and their CPT procedure codes. Hogue Vein Institute follows best practice guidelines for varicose veins and superficial venous disease and is committed to a cost containment strategy and vein procedure selection process that provides better value and protects the bottom line for its patients.
This means that Hogue Vein Institute is a lower-cost provider. To protect its patients’ financial well-being, Hogue Vein will select the lower-cost vein procedures over higher-cost vein procedures when the lower-cost choice provides equivalent evidence-based results. In so doing, Hogue Vein promotes price transparency and patient awareness.
While many providers in the vein care industry are intent on selecting vein procedures that maximize their company’s revenues and profits over delivery of more affordable vein care, Hogue Vein Institute chooses to be a reformer in this fee-for-service marketplace. This means that Hogue Vein is committed to an unusually high standard of business ethics that directly benefits its patients, when other vein care providers are focused on maximizing revenues, profits, and choosing vein treatments and CPT codes that drive up the cost of healthcare to ridiculous, unaffordable levels.
Since 2004, Hogue Vein Institute has established itself as the Regional Leader in Vein Care for Minnesota and surrounding communities, consistently achieving world-class results for its patients, while also delivering more affordable vein care that is world-class and second to none.
How does Hogue Vein Institute accomplish the delivery of more affordable vein care for its patients?
- Hogue Vein Institute believes that it is incumbent for its providers to responsibly select and deliver vein care for its patients in the most effective, least expensive manner, whenever possible to achieve world-class results.
- Hogue Vein Institute provides a FREE Vein Screen for patients that are unsure if they have an underlying medical vein condition. The potential savings for a patient is several hundred dollars by avoiding an unnecessary vein mapping procedure that would be submitted to insurance for payment.
- Hogue Vein Institute uses the lower-cost endovenous laser ablation (EVLA) procedure over higher-cost treatment options when treating symptomatic varicose veins. The potential savings for a patient is hundreds of dollars per procedure.
- Hogue Vein Institute performs multiple EVLA procedures on a single leg on the same day, when clinically indicated, rather than performing a single EVLA procedure multiple times on separate days. The potential savings for a patient is hundreds of dollars per procedure.
- Hogue Vein Institute avoids higher-cost vein procedures that have not been shown to be more effective than proven, lower-cost vein procedures. The potential savings for the patient is hundreds of dollars per procedure.
- Hogue Vein Institute uses lower-cost physician-compounded foam (PCF) for sclerotherapy when treating symptomatic saphenous veins and/or tributary veins and/or reticular veins over higher-cost commercial ready-made “foam in a can”. The potential savings for the patient is hundreds to thousands of dollars per procedure. (Dr. Hogue, founder of Hogue Vein Institute, has written and published an article on PHYSICIAN COMPOUNDED FOAM that has a Google search rank of #1 for the search term “physician compounded foam”. This top ranked article was published in VEIN THERAPY NEWS and makes the case that PCF FOAM STRUCTURE AND VISUAL FOAM QUALITY IS AS GOOD OR BETTER THAN PROPRIETARY “FOAM IN A CAN”)
- Hogue Vein Institute uses the lower-cost outpatient private clinic setting to perform its vein treatment procedures, rather than the higher-priced hospital or ambulatory surgery setting. The potential savings for the patient is up to tens of thousands of dollars per procedure.